EIK1001 + Pembrolizumab and Chemotherapy in Patients with Metastatic NSCLC

A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer (EIK1001-005)

Disease Types: Lung

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer (EIK1001-005)

For More Information:

https://clinicaltrials.gov/study/NCT06246110?term=A%20Phase%202%20Study%20of%20EIK1001%20in%20Combination%20with%20Pembrolizumab%20and%20Chemotherapy%20in%20Patients%20with%20Stage%204%20Non-Small%20Cell%20Lung%20Cancer%20(EIK1001-005)&rank=1